Pfizer Biopharma JV To Go Public In $780M SPAC Union
Cerevel Therapeutics Inc., a Pfizer joint venture focusing on neurological diseases, said Thursday that it was being taken public by a blank check company backed by Perceptive Advisors in a $780...To view the full article, register now.
Already a subscriber? Click here to view full article